Dechra Veterinary Products is encouraging veterinary practitioners to find the cat that has been treated with Felimazole® for the longest period of time, for the chance to win a luxury chocolate hamper.
The company wants to gather profiles of hyperthyroid cats undergoing treatment, including their age and length of treatment, so that it can further inform the veterinary profession about feline hyperthyroidism, the most at-risk cats and how to successfully treat the condition with the leading product Felimazole.
Practitioners simply need to provide details of their patient's age, when the cat was diagnosed with hyperthyroidism and how long it has been treated with Felimazole. Submissions will be entered into a prize draw with the first placed practice and cat's owner each winning a luxury chocolate hamper, while second and third places will receive luxury chocolate boxes.
Carol Morgan, Felimazole product manager at Dechra Veterinary Products says: "The majority of cats suffering with hyperthyroidism are over seven years of age, so we are interested in finding the longest-treated and the current ages of cats on Felimazole. The information we receive from practitioners is invaluable, so we will collate and report our findings to the veterinary profession to ensure it has the most up-to-date information about the disease."
For details of how to enter the competition, contact your local Dechra territory manager, call Dechra on 01743 441632 or email marketing@dechra.com.
VetSurgeon.org member Aubrey Kumm MRCVS, a Joint Partner at Companion Care in Harlow, has become one of the first vets based in the UK to gain the GPCert(Endo) from the ESVPS. He joins a group of just 11 vets who currently hold this certificate in Europe.
Aubrey said: "Although there are over 50 veterinary surgeries offering specialist endoscopic surgery in the UK I wanted to ensure I was as well versed as possible in the latest developments of this method of surgery and the ESVPS certificate offered a comprehensive course, the benefits of which I am now able to pass on to clients."
Aubrey's qualification involved a year of study and several examinable components including case studies and a written exam.
The practice has invested around £60,000 in a Force Triad and two laprascopic cameras, along with various operating scopes, a broncoscope,and other associated equipment.
Aubrey added: "As a practice we are now able to offer less invasive surgery to our clients and their pets and we no longer have to ask clients to travel to distant referral centres."
Invicta Animal Health has announced that that EquiChek test kits are now validated for use with synovial fluid, having originally been validated for whole blood only.
EquiChek is an animal-side test to assess the level of Serum Amyloid A (SAA) which is a major acute phase protein of inflammation in horses.
Invicta says that it has been shown that SAA levels in synovial fluid are not influenced by arthrocentesis*, which makes SAA an ideal biomarker to measure whilst monitoring or assessing joint function.
The company says this is the first test which is able to provide a visual semi-quantitative result within 15 minutes. The test will display 4 lines for a normal level of SAA and sequentially fewer lines depending on the severity of the inflammation.
Rob Watkins, Managing Director of Invicta, said: "EquiChek has proved to be a useful tool in the ambulatory toolkit. The validation of synovial fluid extends the use by allowing real-time monitoring of lameness and intra-articular therapies. Normally whilst medicating joints, excess synovial fluid is discarded. Now this can be utilised to assist diagnosis or to assess the response to medication."
Invicta will be at Stand A16 BEVA Congress 2013.
For further information see www.invictavet.com/ or ring 01403 791313
BCF Technology has launched a competition to win a top of the range digital radiography system from its Cuattro range for 6 months.
To enter the competition, you need to record a short video (up to 2 minutes) explaining how the DR system would transform your imaging function. BCF is asking entrants to be as creative as possible as the voting will be open to the public. The company will pick a shortlist of finalists and then invite the public to vote for a winner on its Facebook page and website.
The competition is open to both small animal and equine vets, for the following systems:
Sarah O'Grady from BCF said: "Having a Cuattro DR system could make a huge difference to either a small animal or an equine practice. For a small animal vet practice that doesn't currently have a DR system, they will love the difference it makes to X-ray studies. Diagnostic images are produced in seconds and re-takes are almost non-existent. A Wireless Slate 3+ can greatly improve the ease of in-stable operations and procedures. With the removal of wires, these procedures run much smoother. You will also be surprised by the improvement in image quality."
The closing date for the competition is 30th November 2013.
To enter your video:
The winner will be required to arrange insurance for the system during the time they have the system. Full terms and conditions can be found on the BCF website.
To find out more visit the BCF website or Facebook page or call +44 (0)1506 460 023.
Organisations including British Veterinary Association (BVA) and the Society of Practising Veterinary Surgeons (SPVS) also responded to the consultation on behalf of members.
The College’s Education Department is now in the process of analysing the consultation responses.
Christine Warman, Head of Education at the RCVS, said: "We are very pleased with the number of responses we have received to this consultation which demonstrates what an important issue CPD, and our approach to it going forward, is for the profession. I am also glad that there was a good split of responses between veterinary surgeons and veterinary nurses as it is important we get as wide a range of views as possible from a wide range of individuals. I’d like to thank everyone who took the time to give us their views.
"Over the coming weeks we will be going through each response with a view to preparing proposals on the next steps for our CPD Working Party’s September meeting."
Proposals are expected to go to the Education Committee and to VN Council in October and then to the November meeting of RCVS Council.
Last year BEVA received a national Antibiotic Guardian award from Public Health England in recognition of its work to promote responsible use of antibiotics. It was the only organisation from the veterinary profession to be shortlisted. BEVA launched its Protect ME antimicrobial campaign in 2012 to coincide with European Antimicrobial Awareness day. The Association has launched additional resources each year to facilitate compliance and educate the public about the importance of antimicrobial awareness.
This year, to recognise World Antibiotic Awareness Week (16th to 22nd November, 2016) and European Antibiotic Awareness Day (18th November), BEVA is encouraging members to document their efforts to reduce the use of critically important antibiotics.
To enter for the award, veterinary surgeons need to share practice sales data (in mls) of chosen antibiotics. Practices that document a reduction in antibiotic sales of these drugs will be presented with a BEVA Antibiotic Champion Award to endorse their commitment to responsible use of antibiotics and to help promote public awareness of the campaign. Members are also encouraged to sign up to be antibiotic guardians at www.antibioticguardian.com
Gayle Hallowell, Co-Chair of the BEVA Health and Medicines Committee said: "We are extremely proud of the equine veterinary profession’s commitment to the responsible use of antibiotics. We hope the introduction of our Champion Award will inject new vigour into efforts to continue to reduce the use of our precariously limited antibiotic resources."
To apply for BEVA Antibiotic Champion Award status visit http://www.beva.org.uk/Antibiotic-Champion-Award The BEVA Protect ME toolkit is free to BEVA members and can be downloaded at www.beva.org.uk.
The leaflets are designed to be used as part of the veterinary consultation and provide information to help owners understand what is involved in the examination, including the reasons for the procedure, the preparation required, any associated risks, and what happens during and after the examination.
They are available in a PDF format which can be printed and stamped with the veterinary practice details or emailed to clients.
Philip Lhermette, Principal of Elands Veterinary Clinic, specialist in minimally invasive surgery and Past President of the BSAVA said: “Minimally invasive surgery is becoming commonplace in general veterinary practice and is much sought after by clients, especially for routine procedures such as bitch spays.
"It is important that clients are properly informed of all the risks and benefits of a minimally invasive procedure and these leaflets provide the first opinion practitioner with an ideal means of providing such information in a succinct and easily understood format."
The new leaflets are available via the BSAVA Library here: https://www.bsavalibrary.com/content/cilgroupprocedures.
Access to the entire range of client information leaflets (including canine and feline behaviour, exotic pets, and medicines) is available for an annual subscription of £40.
BSAVA members have access to these leaflets as part of their membership benefits.
If you have any suggestions for further client information leaflets, email: publications@bsava.com.
The first webinar Does Ease of Use Have to Come at the Expense of Efficacy? is presented by Claire Harrison BSc (Hons) RVN VTS (Dentistry) AFHEA, Dentistry Nurse at the Hospital for Small Animals at the Royal ‘Dick’ School of Veterinary Studies.
Claire will consider the best practice of daily toothbrushing for oral homecare and explore what practices can do to contextualise care for the many owners who struggle to achieve this goal.
Animalcare highlights research which shows that the number of pet owners who brush their pet’s teeth daily is very small: one study in Sweden suggested that only 8% of dog owners and 4% of cat owners met this target¹.
Senior Brand Manager Eleanor Workman Wright said: “With periodontal disease so common in dogs and cats, supporting owners to maintain an oral health regime for their pet is essential.
"Daily toothbrushing remains best practice but many owners are just not able to do this, so it is important to suggest effective alternatives in order to protect their pet’s oral health.
“During this webinar series dental experts will explore a range of approaches which can be used with owners & pets throughout the different stages of their pets’ lives, either as an alternative to toothbrushing, or as part of a programme to build up to toothbrushing.”
To register, visit: www.animalcare.co.uk/dentalwebinars
Further webinars in the oral homecare series will be delivered in January 2023.
Reference
Intervet reports that a clinical trial of 489 cows on dairy farms in the south west last spring and summer has demonstrated some excellent efficacy levels for treating and preventing intramammary infections in the dry period and early lactation.
The trial compared Cephaguard® DC and a 600mg cloxacillin dry cow tube (OEDC) on its own, and in combination with a teat sealant. Cephaguard DC demonstrated superior efficacy in terms of infection prevention during and after the dry period relative to cloxacillin alone, and was statistically equal to the combination treatment group.
Indeed, cows treated with cefquinome (Cephaguard DC) were around half as likely to develop mastitis in the first 100 days post calving than those treated with cloxacillin alone.
The trial also demonstrated excellent efficacy levels against existing Strep. uberis infections when compared with cloxacillin (see table).
DRY PERIOD CURE RATES (%) OF KEY MASTITIS PATHOGENS
Cephaguard DC
Cloxacillin (600mg)
Strep. uberis
100
75
E. coli
92.31
Coagulase +ive Staphs
66.67
S. dysgalactiae
Intervet’s large animal veterinary adviser Rosemary Booth said: "With Intervet’s Cephaguard bacteriology scheme showing that Strep. uberis is responsible for 18% of high cell counts and 23% of clinical cases, the dry period offers a fantastic time to treat this persistent pathogen."
She added: "Several weeks of exposure to an effective dry cow antibiotic provides a particularly good opportunity to kill the cow-adapted strain of Strep. uberis. It lives quite happily in the udder and is tougher and harder to kill than the environmental strain."
The cloxacillin-treated group was significantly more likely to develop clinical mastitis compared to the cefquinome-treated group, as is shown in the table below:
First quarter clinical mastitis cases up to 100 days post calving in quarters not sampled in transition
OEDC
Total major pathogens
12
21
Total with enterobacterial involvement
6
Total cases
26
41
According to Intervet, the study results suggest that reviewing dry cow therapy this summer, and moving to a cefquinome-based treatment may help reduce the incidence of mastitis. Further information on the study will be presented at the Large Herd Seminar on 30 June 2008 and is available from Intervet.
Some interesting statistics from insurers Petplan today. Turns out that almost a third of 3000 pet owners surveyed by the company admitted accidentally injuring their pet, resulting in an average vet bill of £170.
Nearly 6 out of 10 owners admitted stepping on their pet, while 21% confessed to dropping them. The next biggest threat posed to pets by their owners was accidental poisoning.
The survey found that dogs are most likely to be stepped on, whilst guinea pigs are most likely to be dropped by their overly affectionate owners.
The survey also found that 1/3rd of pets hurt themselves jumping off furniture, and one in five have been injured running in front of a car.
More than a third of pets injure themselves eating something they shouldn't, including the dog that swallowed a pair of knickers, which ended up costing £1,200 to retrieve.
Last year's event generated an impressive amount of media coverage about ticks on Radio Four's Today programme, BBC Radio 1, 2 and 5, BBC TV Breakfast, BBC TV News, Good Morning Britain, ITV News and Channel 5 news, amongst others, providing an opportunity for practices to convert heightened public awareness into more protected pets.
Amanda Melvin, Small Animal Marketing Manager at MSD Animal Health said: "Last year’s Tick Awareness Month was a great success thanks to the high involvement of veterinary practices. We would like to give as many practices as possible the chance to get involved this year so are urging surgeries to get in touch early and we will ensure you get a pack of support resources for this nationwide event."
For further information, contact your MSD Animal Health representative or visit: www.bigtickproject.co.uk.
The pack contains species-specific microchipping law guides, a practice registration guide, a cat chipping cheat sheet, flyers about registration and flyers about Identi’s silent microchipping scanner.
The company has also produced three short videos with more information for vet professionals about Identi, what it does, registering microchips and compulsory cat microchipping.
Tammie O’Leary, commercial lead at Identi, said: “From June 10th, it will be compulsory that owned cats in England are microchipped and registered in the same way.
"With these changes imminent, it is important that staff are up to date with the relevant legislation and the potential consequences of pet keepers not adhering to the law.
"identi’s new Practice Pet Protection Pack will provide busy vet professionals with comprehensive information answering a wide range of microchipping questions in a quick and simple format.”
For a copy of the Practice Pet Protection Pack, email: contact@identichip.co.uk
Purina has launched a FortiFlora veterinary support pack designed to help veterinary professionals advice owners about their pet's intestinal health and balance.
The support package includes a "Training Toolbox" with Lunch and Learn sessions to help guide veterinary professionals through the introduction of Fortiflora to an owner. It explains the indications, ingredients, benefits and summarises the added value in prescribing to animals with specific health issues. In addition, there are leaflets for owners explaining what probiotics are and how they can help support a pet's intestinal health on a daily basis, as well as some testimonials from owners explaining how Fortiflora has helped their pets. Promotional bunting and posters are designed to raise awareness in the waiting room, and for a short time there is a promotional pillow pack available to allow clients easy access to a short course of FortiFlora.
In a recent survey of pet owners conducted by Purina, 66% of respondents said their dog had suffered with digestive problems and 80% said they would be willing to make a change to their dog's diet to improve their digestion.1
Purina says that providing a supplement such as FortiFlora is also recommended as a nutritional supplement to help with diarrhoea associated with stress, antibiotic therapy, diet change and acute enteritis. The company claims it can also help with situations associated with stress such as moving house, vet visits and shows.
Chris Nickson, Senior Brand Manager at Purina said: "Intestinal upset is a very common problem for dogs as our research highlighted. The aim of this support pack is to help vet practices initiate the conversation with owners to ensure they are aware of the benefits that a nutritional supplement like FortiFlora can offer."
FortiFlora is suitable for use in cats and dogs of all ages. Animals should be fed one sachet of FortiFlora per day sprinkled over the pet's regular food.
For more information or to request a FortiFlora support pack, call Purina on 0800 212 161.
Novartis Animal Health has announced the results of a survey of dairy and beef farmers which found that 39% of those who found Bovine Viral Diarrhoea (BVD) present in their herd did not then go on to test for persistently infected (PI) animals.
Any calf born from a BVD persistently-infected cow will be born Persistently Infected with the virus and cannot be cured. As a result, future vaccination of this animal against the virus is rendered ineffective and the affected animal will be a source of the virus, spreading infection within the herd.
With young cattle being the source of PI's and reservoirs of infection within a herd, failure to test, identify and then deal with PI livestock represents the most significant problem facing the industry when trying to eradicate BVD.
Professor Joe Brownlie from the Royal Veterinary College and current chairman of the BVD Scientific and Technical Working Group, said: "Of the 61% of farmers that did do follow up tests for PI's once BVD had been detected in their herd, one third found one or more PI's within the stock holding.
"However, one third of farmers who identified having active BVD infection in their herd then failed to go on and carry out individual animal testing; of those that did, nearly half discovered one or more individual PI's within their herd".
"It just shows that the disease can be hidden, and farmers could be in the dangerous position of potentially missing PI animals that are in their herd; PI's that can continue to spread the BVD virus amongst other cattle and pass on their PI status to any calves they produce. It is hugely important to be thorough and consistent in your testing as part of an agreed herd health plan"
The survey also indicated that action needs to be taken to educate farmers about what to do once BVD and, most significantly, PI's are discovered amongst a herd.
Professor Brownlie said: "There is much evidence from this survey to encourage the industry in how it is tackling this disease, however there is still a great need for clear direction. The survey indicated that 20% of farmers wrongly believe that PI animal's will eventually become non-infective and that 25 % believe that calves born of PI cows will not always have PI calves themselves.
"All of these perceptions are incorrect and can lead to reservoirs of the disease being allowed to remain not only within individual herds, but geographical regions as well; seriously hindering the eradication of the virus in England and Wales".
With nearly half of farmers saying that they talked to vets - their main source of information about BVD - only once or less a year, Professor Brownlie said it is unsurprising that many farmers did not show a greater understanding of BVD beyond biological side effects present in the infected cattle: "About 50% of farmers surveyed were unsure as to what types of tests need to be carried out to detect the infection in their livestock and 32% of respondents were unaware that correct vaccination of livestock against BVD can protect both the cow and unborn calf".
Novartis says that while BVD is still regarded by farmers as one of the top bovine diseases, other health issues such as mastitis and tuberculosis are given much greater attention. This lack of focus on BVD is exacerbated by the lack of sound information of the financial implications of the infection on their herd.
Professor Brownlie said: "The side effects of BVD appear to be overlooked in financial terms, but the infection can severely hinder a herd's financial productivity due to poor health, reduced milk yield and loss of reproductive efficiency.
Caroline Dawson from Novartis Animal Health said:"Perhaps by aiding understanding of the financial cost of the virus, we can encourage farmers to take more proactive steps to combat BVD. As such, I am pleased to announce that that the FAB panel has initiated a follow on project to carry out detailed research with regards to the financial impact of BVD on farms and is due to report findings in the new year".
(Photograph shows, left to right, James Russell MRCVS (McMurtry & Harding), Caroline Dawson (Novartis Animal Health), Tony Brooks (Brighthams Farm), Professor Joe Brownlie(RCVS)
Despite being a common disease, CVS says very little research has been undertaken into EPD in the UK.
In addition, numerous different treatments are currently used for EPD, for which there is not always robust scientific evidence.
The CVS study, which started in 2022 and will continue till early 2024, involves 20 practices.
Samples have been collected from over 70 cases from horses that have been diagnosed by EPD throughout the UK.
Full blood profiles have been assessed, in addition to bacterial culture analysis of the lesions, PCR analysis for dermatophytes (ringworm fungi), microscopy for ectoparasites (mites) and skin cytology.
An owner questionnaire has also been completed to gather information on EDP management.
Each horse’s lesions have been graded and descriptive data relating to the lesions were recorded.
Data collection is now complete and a team of researchers, led by vet Manuela Diaz Ramos, has started analysing the data.
A full report on the findings, along with treatment and management recommendations, is expected to be presented at a scientific conference later this year.
Rig Vet Recruitment has added a new title to its range of personnel recruitment guides with the introduction of “Rig’s Practice VN Guide”.
The guide covers all the issues you might face when employing a locum nurse, and gives a handy checklist of things to cover with your temporary employee to help make sure that he or she gets up to speed as fast as possible.
“We were so pleased with the positive responses we received when we launched the locum vet guides last year that locum vet nurses’ versions were an obvious next step,” said Justin Carpenter, Rig Vet Recruitment Managing Director.
He added: “At the end of last year, we conducted a survey among some vet nurses and frankly were surprised at how little information on practice admin and procedures some VNs were given on their first day,” Justin continued. “For example, 88 per cent were not given a formal induction, 78 per cent were not advised on fire and health & safety regulations, and when expected to undertake reception work, 97 percent were not informed on phone protocols or appointment systems.
The guide is available free of charge from Rig Veterinary Recruitment: enquiries@rigvets.co.uk
Rig Vet Recruitment are on stand number 719 at BSAVA Congress 2008.
Animalcare has launched Florgane, a novel, patented, long acting florfenicol 300mg/ml suspension which the company says has significant advantages over existing organic solvent-based florfenicol products on the market when used for the treatment and prevention of bovine respiratory disease (BRD).
Florgane is an aqueous, low viscosity advanced formulation, which, claims Animalcare, means that it is easier to inject even at temperatures as low as 5°C. Low temperature syringeability is important, as a large number of calves may need to be treated during colder weather at a time when the challenge from infectious agents is greatest. A syringeability study apparently demonstrated that Florgane is up to five times faster to administer when compared to the leading florfenicol non-aqueous formulation.
A paper on the treatment of naturally occurring respiratory disease with Florgane was presented recently at the British Cattle Veterinary Association (BCVA) Congress in Torquay. According to the company, the multi-centre field studies in Belgium, Germany and Italy, in over 400 cattle with bodyweights ranging between 73-180kg, demonstrated that Florgane given by a single intramuscular injection, at a 25% lower dose of 30mg/kg, is as efficacious as non-aqueous florfenicol 40mg/kg administered by subcutaneous injection, measured by treatment success and relapses.
Post mortem examination at day 27 (meat withdrawal of 37 days) confirmed that, despite being given via the intramuscular route, Florgane is well tolerated at the site of injection due to its aqueous base and physiological pH. Maximum volume per injection site is 15ml allowing calves up to 150kg to be treated.
Animalcare adds that a further advantage of Florgane is that it persists in plasma above the MICs for the three most common pathogens for significantly longer than conventional extended action 300mg/ml florfenicol solution preparations - thereby prolonging bacterial killing time. Therefore, owing to its improved bioavailability and excellent pharmacokinetics, Florgane can be given at an easy to remember dose of 1ml per 10kg.
Tony Liepman, Marketing Manager at Animalcare said: "Using Florgane will result in faster administration, resulting in less stress for the calves and a saving in time and money for the farmer."
Florgane is presented in polypropylene 100ml and 250ml multi-dose vials with a three year shelf-life.
For more information, visit www.animalcare.co.uk
Allison Henry, product manager at Ceva Animal Health, said: "We have a very good relationship with the Royal Dick School of Veterinary Studies and it was an easy decision for us to support its students with this donation. Antimicrobial resistance is a very hot topic for human and animal health and as a manufacturer we have a duty to contribute as much as we can. Students are the next generation of veterinary surgeons and if we can educate them about antimicrobial resistance early on it will have a long term positive effect ensuring these products are used as rationally as possible and only when necessary."
Dr Tim Nuttall, head of dermatology at the Royal Dick School of Veterinary Studies, added: "We are very grateful to Ceva Animal Health for its generous support of our student research projects into antimicrobial resistance. These give our veterinary students an immensely valuable insight into the problems of antimicrobial resistance and helps them find novel approaches to counter this threat. This will not only benefit their careers but will also be of great value to vets, animals and owners throughout the world."
Ceva's efforts to support practices in their efforts to use antibiotics responsibly have continued in 2017 with the launch of GRAM (Guidance for the Rational use of AntiMicrobials), a guide on the rational use of antimicrobials in dogs and cats.
For more information on GRAM and sustainable antibiotic use, contact your local Ceva Animal Health territory manager.
Vets Now will be opening the doors to its new clinic in Caterham on 31 March.
The company, which was launched in 2001, recently opened its Northolt clinic in North London and is now delighted to be offering an out of hours service in the South London area.
Based at The Animal Hospital, in Coulsden Road, Caterham, the clinic is the 31st Vets Now clinic to open in the UK and will provide Out of Hours cover for a number of member practice clinics in the East Surrey area.
Vetoquinol is offering veterinary surgeons and nurses the chance to win up to £500 worth of vouchers of their choice with Ipakitine, the phosphate binder.
To take part, call 0800 1698197 and request a copy of the company's renal guide, wall chart and an entry form. Then answer three simple questions and be in with a chance to win a first prize of £500 worth of vouchers. The second prize is £300 worth of vouchers, with £200 of vouchers for third prize.
Simon Boulton, product manager said: "Our renal guide is designed to illustrate factors which can affect both quality and quantity of life. These include hyperphosphataemia, hypertension, proteinuria, azotaemia and fibrosis in renal disease." The renal guide and wall chart contain information on the appropriate management of these factors.
WebLeC has launched a monthly online equine CPD service.
One hour live interactive sessions will take place every third Thursday at 7:30 pm. A single meeting costs £30 plus VAT, or savings can be made by taking out a flexible subscription that allows the user to choose any 12 meetings for the cost of 10 over a period of up to 24 months.
The next meeting is on 22nd September and is entitled: Colic Decision making: When to wake up the surgeon and what pain control to use. The presenter is Debra Archer form the University of Liverpool. Further details and registration links can be found at: http://www.ledstonequine.co.uk/weblec_lectures/colic.html
In addition, a recording of WebLeC's 6th meeting, which was held in partnership with BEVA and the VDS and dealt with the new guidelines and forms for pre-purchase examinations of horses, is now available to view free online at: www.bitly.com/weblecbevaPPE. Use the password: b3va to get access, and you will receive a CPD certificate if you fill in the registration form.
WebLeC has also been asked to host BEVA's online CPD and will be announcing further details of their meetings soon.
The webinar is the first of several events which will focus attention on patients owned by the estimated 80% of owners who feel that their pets with canine osteoarthritis (OA) may be suffering from off-days that can be associated with breakthrough pain¹.
During the session, Matt will explain the impact breakthrough pain has on the pet and owner and how to approach it more effectively using analgesic and rehabilitation tools and strategies.
James Beaumont, Marketing Manager at Animalcare, said: “Veterinary surgeons have told us that they estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain.²
"Additionally, a proportion of pet owners state their dogs experience off-days and believe their pet suffers as a result of the condition³."
Animalcare says that some of the main factors in osteoarthritis breakthrough pain can include variable plasma drug levels between doses, intermittent treatment protocols or poor owner adherence with the vet’s recommendation, flare-ups and disease progression.
To register for the event, visit: https://tinyurl.com/43bm8mdx. All those who register will also be able to view a recording and enter a free prize draw for the chance to win tickets to attend London Vet Show live in November.
This brings the total number of oncology specialists to four, within a service comprising 12 oncology professionals.
After getting her bachelor’s degree in biology from Duke University, Sarah (pictured right) enrolled at the University of Pennsylvania School of Veterinary Medicine, from which she graduated summa cum laude (with highest honours) in 2017.
Sarah stayed on at Penn to complete an internship in small animal medicine and surgery followed by a residency in medical oncology.
She became a diplomate of the American College of Veterinary Internal Medicine in 2021 and joined the team at Davies in October 2021.
Sarah said: “I joined Davies for the opportunity to collaborate with specialists spanning all aspects of veterinary medicine.
“This allows me to provide the best care for my patients and contribute to the future of veterinary medicine.
"It is a privilege to work with so many kind, motivated and intelligent individuals that share these same goals.”
Taking over from Carl Gorman, Julian says his focus is to continue the work undertaken this year as part of a ‘programme of change’ for BSAVA, that will continue to promote the strong sense of community within the membership and the wider profession.
Speaking at the BSAVA AGM, Julian said: “I am very humbled as I stand here today as your 67th President. It is certainly the pinnacle of my veterinary career, and the greatest honour yet bestowed on me in life.
"We continue to live in exciting times at BSAVA, and as ever, I join a team of utterly amazing staff at Woodrow House.
“I really do believe that the BSAVA will continue to go from strength to strength and will continue to maintain its relevance and position as the indispensable voice of the small animal veterinary profession.”
Julian started volunteering for the BSAVA after his graduation within the Southeastern Regional committee, becoming Chair of the committee after a few years.
He then became part of the BSAVA Education Committee, BSAVA PetSavers Grants Awarding Committee, and was lately part of the Publications Committee.
He then joined the Presidential ladder two years ago as Junior Vice President.
Outside of his volunteering for the BSAVA, he was at Crossways Vets in West Sussex for 17 years, initially as a partner, then as an owner, and finally as a Clinical Director.
He has since stepped down from the practice to devote his time to being BSAVA President this year.
The Badger Trust's legal challenge to Defra's plans for targeted badger cull pilots has failed in the High Court on all three grounds.
Whilst the RSPCA has expressed its disappointment, the British Veterinary Association and British Cattle Veterinary Association have welcomed the judgement.
BVA President Carl Padgett said: "We are pleased that the High Court has ruled Defra's policy lawful and that the pilot badger culls can now go ahead.
"The BVA and BCVA believe that the government's approach has been robust and justifiable as it is based on our current scientific knowledge.
"Bovine TB is a devastating disease and we must tackle the disease in wildlife alongside cattle controls if we are to get on top of it."
David Bowles, the RSPCA's Director of Communications, said: "We are bitterly disappointed that the UK Government in England is ploughing on with plans to kill badgers but the fight is not over yet.
"We believe culling is not a long-term, sustainable solution and will be of little help in reducing the disease - perhaps even making things worse in some areas. It will wipe out huge numbers of this much-loved species, virtually eliminating badgers from these areas, including many animals which are healthy.
"It is not as if there aren't alternatives to a cull. Vaccination could be a more effective and sustainable way of dealing with the disease, and one which does not involve killing most of the badger population in very large areas of the countryside."